Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

31 Jul 2012 07:00

RNS Number : 8643I
Creston PLC
31 July 2012
 



31 July 2012

 

Creston plc

Interim Management Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2012 to date.

 

Trading update

 

For the three months to 30 June 2012 (the 'Period'), the Group reported revenue growth of just over 1 per cent compared to the same period last year. As anticipated, the decline in retained revenues reported in the final quarter of the last financial year has impacted the first three months of trading in the current financial year, and as a consequence, like-for-like1 revenue for the first quarter was down just under 7 per cent, compared to the same period in 2011.

 

Communications

The Group's largest division, Communications, has performed broadly in line with the prior year in terms of first quarter revenue. TMW, the Nelson Bostock Group and The Real Adventure have all delivered growth in revenue with some significant new business wins. This new business includes: TMW being appointed to work on Sony Mobile's global social media strategy and winning projects from new clients such as BBC Good Food; the Nelson Bostock Group being hired by Cartoon Network; and The Real Adventure winning its first global account for Danone Baby Nutrition, helping the team to develop pioneering CRM strategies across Europe and beyond. EMO experienced a decline in first quarter revenue compared to the same prior year period due to the decline in retained revenues reported at the end of the last financial year, however, it too is experiencing an uplift in new business opportunities. The division overall, with its good new business performance and pipeline, and a full year effect of last year's cost reductions, is positioned for another year of growth.

 

Health

The stabilisation of the healthcare sector has continued and the division saw a small increase in like-for-like revenue during the first three months compared to the prior year period. The division is experiencing an increase in new business opportunities, winning more work from new and existing clients and while structural reform remains ongoing in the sector, the Group believes it is well placed to benefit from the resulting opportunities.

 

Insight

As previously reported ICM's performance in the last financial year has, as expected, continued to impact trading during the Period. Significant cost reduction actions were undertaken at the end of the last financial year and management will continue to review the business closely to ensure costs remain aligned to performance as revenue increases again. The wider division's focus on developing further expertise in new research technologies and digital platforms is creating good new business opportunities, and our healthcare focussed start-up company has added three new clients since the start of the new financial year.

 

Outlook

While on a like-for-like basis the Group has had a slower start to the new financial year, primarily as a result of the previously reported lower retained revenues at the end of the last financial year, there have been encouraging new business wins and opportunities across the Group.

 

The Board is pleased with the performance of its recent acquisition The Corkery Group and expects a positive impact from new client wins. However, we naturally remain cautious given the macro environment.

 

 

For further information please contact:

 

Creston plc

+ 44 (0)20 7930 9757

Don Elgie, Group Chief Executive

Barrie Brien, COO/CFO

M:Communications

+44 (0)20 7920 2339

Elly Williamson

 

About Creston plc

Creston plc (LSE: CRE) is a marketing services company focused on insight-led communications. The Group delivers a range of marketing services, including advertising, brand consultancy, CRM, digital and direct marketing, health communications, local marketing, market research, PR and social media marketing to a broad spectrum of blue-chip global clients. Our insight companies give us a real edge, providing the analytic intelligence to enable us to truly understand, influence and inspire consumers and it's that insight-led intelligence that drives our creativity. www.creston.com


1 Excluding the results from any acquisitions made during the current year, like-for-like compares current year performance to the prior year, adjusting the current year to only include the results of prior year acquisitions for the commensurate period of ownership

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAAXEDSNAEAF
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.